Free Trial

Nanobiotix (NBTX) SEC Filings & 10K Form

Nanobiotix logo
$4.40
+0.24 (+5.77%)
(As of 11/1/2024 ET)

Recent Nanobiotix SEC Filings

DateFilerForm TypeView
10/31/2024
5:00 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
4:24 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/12/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
5:00 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/22/2024
5:00 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/21/2024
4:30 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
3:49 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
3:23 PM
Nanobiotix (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/17/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/09/2024
4:07 PM
Artal International S.C.A. (Filed by)
Nanobiotix (Subject)
Form SC 13G/A
02/08/2024
7:27 PM
Nanobiotix (Subject)
Qatar Investment Authority (Filed by)
Form SC 13G/A
02/02/2024
3:32 PM
JOHNSON & JOHNSON (Filed by)
JOHNSON & JOHNSON (Filed by)
Nanobiotix (Subject)
Form SC 13G/A
01/29/2024
9:53 AM
BAILLIE GIFFORD & CO (Filed by)
Nanobiotix (Subject)
Form SC 13G/A
12/26/2023
5:05 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2023
3:15 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2023
3:32 PM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
8:00 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2023
3:16 PM
Nanobiotix (Subject)
Qatar Investment Authority (Filed by)
Form SC 13G
11/08/2023
6:53 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
6:02 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
3:12 PM
Nanobiotix (Filer)
Form 424B5
11/02/2023
3:36 PM
Nanobiotix (Subject)
Form FWP
11/02/2023
9:56 AM
Nanobiotix (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NBTX) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners